MTOR and non-small cell lung carcinoma: This caused acquired chemoresistance in non-small cell lung cancer (NSCLC) via phosphorylation of paxillin resulting in increased Bcl-2 expression and cell survival26, and increased Akt/mTOR phosphorylation via activation of p38MAPK27–29.